Navigation Links
Parents, Kids Enjoyed Kids Korral at Annual Komen Atlanta Race for the Cure
Date:5/12/2009

Bright Starts(R) brand was lead sponsor for activity area at May 9 event

ATLANTA, May 12 /PRNewswire/ -- Bright Starts, a registered trademark of Kids II, Inc. hosted the first Bright Starts Kids for the Cure Korral at the 19th Annual Komen Atlanta Race for the Cure this past Saturday, May 9 at Atlantic Station in Midtown Atlanta, Ga. Parents and kids who participated in the race received a refreshing drink as they enjoyed fun activities like carnival games, caricature sketches and prize drawings in this special expo area.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090512/CL15773)

Participants also stopped by the expo area to nominate someone for the annual Bright Starts Pink Power Mom(TM) contest. This contest selects eight women who have survived breast cancer and used their experience to make a difference in the lives of others who are also affected by the disease. Each Bright Starts Pink Power Mom(TM) will receive a prize package which includes a $5,000 donation to the charity of her choice. Nominations will also be accepted online at www.pinkpowermom.com through June and winners will be announced at the end of August.

In addition to conducting the annual Bright Starts Pink Power Mom(TM) contest, Bright Starts also contributes a portion of the proceeds from the sale of its popular Pretty in Pink Collection to breast cancer research. These toys and baby gear were created to help give baby girls a brighter tomorrow with every purchase. Items include the Bounce-A-Bout(TM) Activity Center, Cradling Bouncer, Swing Anywhere(TM) Portable Swing and the Tummy Cruiser(TM) Prop & Play Mat among others.

"This year we really wanted to do something a little more special around the Komen Atlanta Race for the Cure event," said Kids II Vice President of Marketing Miles Bohannan. "We feel strongly that we have accomplished that with our sponsorship of the Kids Korral. It's a perfect way for our company to make a meaningful contribution to this incredibly important fundraising event in Atlanta. We applaud Komen Atlanta's dedication to finding a cure and proudly support this year's Race for the Cure."

The Komen Atlanta Race for the Cure is Georgia's largest and most successful education and fundraising event for breast cancer. Since its inception in 1991, the Atlanta affiliate has raised more than $19 million for breast cancer research, local grassroots organizations, community agencies and support groups to help provide assistance to breast cancer patients and their families.

About Kids II, Inc.

One of the world's fastest growing infant products companies, Kids II has been reinventing baby toys and gear for three generations and counting. Kids II designs, distributes and markets nearly 100 products under its Bright Starts(R) brand name. Kids II also holds the license to design and manufacture products for Baby Einstein(TM) and Boppy(R). The company's award-winning products have revolutionized the industry time and time again.

Headquartered in Atlanta, Georgia, Kids II has international affiliate operations in Australia, Canada, Europe, China, Hong Kong, Japan and Mexico. Visit www.kidsii.com

    Contact:
    Kristie Anderson
    kristie.anderson@kidsii.com
    (678) 597-1855


'/>"/>
SOURCE Kids II, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Parents, Kids Invited to Kids Korral at Annual Komen Atlanta Race for the Cure
2. Alarming Rise in Autism Brings Hundreds of Parents, Researchers and Clinicians Together from Around the World to Atlanta April 17-19, 2009
3. Workshop Helps Parents, Kids Talk About Sex
4. Doctors of Optometry, Parents, Educators and Legislators Applaud New Illinois Law Requiring Comprehensive Eye Exams for Children Starting School
5. Playtex(R) Offers Free Non-BPA Baby Bottles to Parents, Will Stop Using BPA in All Products This Year
6. AARPS New Book Caring for Your Parents, Online Channel, and PBS TV Special Launch to Provide Consumers With Integrated Resources for Caregiving
7. Nektar Therapeutics to Present at the Deutsche Bank 34th Annual Health Care Conference in Boston
8. KLRI Releases 3rd Annual Report On Years Top Longevity Research Findings
9. Onyx Pharmaceuticals to Present at the Deutsche Bank 34th Annual Health Care Conference
10. BurrellesLuce Sponsoring Track on 'Advanced PR Strategies' At Annual Industry Summit to Be Held May 17-19 in New York
11. Hilary Duff to Light Empire State Building Commemorating 24th Annual AIDS Walk New York
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... December 05, 2016 , ... ... at the 2016 Anti-Aging & Beauty Awards at The Aesthetic & Anti-aging ... Anti-aging Medicine European Congress (AMEC) brings together the industry’s leading scientific experts, ...
(Date:12/5/2016)... Columbus, OH (PRWEB) , ... December 05, 2016 ... ... novel engineering solution called the CardioQuick Patch® significantly improves the reproducibility and accuracy ... usability in various healthcare settings. , Over the last 60 years, studies ...
(Date:12/4/2016)... York, NY (PRWEB) , ... December 03, 2016 ... ... largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the ... services – hosted its first Swirl: A Wine Tasting Event in New York ...
(Date:12/4/2016)... ... December 03, 2016 , ... While James Earl Jones is known ... for in a show called "Front Page". One of the forthcoming episodes examines mammogram ... rates have plummeted in large part due to early detection. Like any other disease, ...
(Date:12/4/2016)... ... December 03, 2016 , ... ... Entrepreneurial Company in the Dallas area” Tuesday evening at the 26th Annual SMU ... presented by SMU's Cox School’s Caruth Institute for Entrepreneurship. Dallas 100™, co-founded by ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... December 5, 2016 PharmaBoardroom today releases its new ... ... This report offers companies, investors, policymakers, and stakeholders crucial insight into ... Europe , home to some of the world,s most important ... in Novartis and Roche, and with a number one ranking globally in ...
(Date:12/4/2016)... CAMBRIDGE, Mass. , Dec. 4, 2016 /PRNewswire/ ... a leader in discovering and developing targeted kinase ... announced data from its ongoing Phase 1 trial ... of patients with advanced systemic mastocytosis (SM). Blueprint ... selective inhibitor of D816V mutant KIT. Approximately 90 ...
(Date:12/4/2016)... Dec. 3, 2016 Sickle cell disease (SCD) ... red blood cells that get stuck in veins and ... organ failure, and complications leading to death. Each year, ... SCD, and most of them lack access to comprehensive ... established long-term therapy for SCD, a pill called hydroxyurea ...
Breaking Medicine Technology: